Canada Mycoplasma Testing Market Size & Outlook, 2023-2030
Canada mycoplasma testing market, 2018-2030 (US$M)
Related Markets
Canada mycoplasma testing market highlights
- The Canada mycoplasma testing market generated a revenue of USD 45.4 million in 2023 and is expected to reach USD 126.4 million by 2030.
- The Canada market is expected to grow at a CAGR of 15.8% from 2024 to 2030.
- In terms of segment, kits & reagents was the largest revenue generating product in 2023.
- Services is the most lucrative product segment registering the fastest growth during the forecast period.
Mycoplasma testing market data book summary
| Market revenue in 2023 | USD 45.4 million |
| Market revenue in 2030 | USD 126.4 million |
| Growth rate | 15.8% (CAGR from 2023 to 2030) |
| Largest segment | Kits & reagents |
| Fastest growing segment | Services |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Instruments, Kits & Reagents, Services |
| Key market players worldwide | Thermo Fisher Scientific Inc, Lonza Group Ltd, Merck KGaA, Charles River Laboratories International Inc, Asahi Kasei Corp, Sartorius AG, Eurofins Scientific SE, PromoCell GmbH, ATCC, InvivoGen |
Other key industry trends
- In terms of revenue, Canada accounted for 4.8% of the global mycoplasma testing market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. mycoplasma testing market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 126.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Mycoplasma Testing Market Scope
Mycoplasma Testing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Canada mycoplasma testing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to mycoplasma testing market will help companies and investors design strategic landscapes.
Kits & reagents was the largest segment with a revenue share of 56.17% in 2023. Horizon Databook has segmented the Canada mycoplasma testing market based on instruments, kits & reagents, services covering the revenue growth of each sub-segment from 2018 to 2030.
Canada mycoplasma testing market is witnessing rapid growth due to the increasing healthcare expenditure and expanding biopharmaceutical industry, which fuels the demand for cell culture products for research & clinical purposes. Key companies operating in Canada include bioMérieux, Eurofins Scientific, Thermo Fisher Scientific Inc., and others.
Furthermore, extensive R&D initiatives being undertaken by local players for the treatment of cancer and other chronic diseases due to continuous public-private funding are anticipated to create lucrative opportunities for mycoplasma testing products in the country.
In addition, increasing government investments facilitating the development of cell culture solutions and highly specialized research infrastructure in the country are anticipated to fuel market growth for mycoplasma testing products and services. In May 2023, AbCellera announced that they had received funds worth USD 515 million to construct an antibody manufacturing facility in Canada.
Reasons to subscribe to Canada mycoplasma testing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Canada mycoplasma testing market databook
-
Our clientele includes a mix of mycoplasma testing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada mycoplasma testing market , including forecasts for subscribers. This country databook contains high-level insights into Canada mycoplasma testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Canada mycoplasma testing market size, by product, 2018-2030 (US$M)
Canada Mycoplasma Testing Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
